Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission - Vevera, Jan; Fišar, Zdenĕk; Kvasnička, Tomáš; Zdeněk, Hanuš; Stárková, Lucie; Češka, Richard; Papežová, Hana (Psychiatry research, 2005)
Keywords: Adult; Adult and adolescent clinical studies; Anticholesteremic Agents - adverse effects; Biological and medical sciences; Blood Platelets - metabolism; Cholesterol - blood; Cholesterol - deficiency; Depression; Depressive Disorder, Major - chemically induced; Depressive Disorder, Major - metabolism; Disruptive, Impulse Control, and Conduct Disorders - metabolism; Drug toxicity and drugs side effects treatment; Female; Fluorescence Polarization; Humans; Hypercholesterolemia - drug therapy; Impulsivity; Male; Medical sciences; Membrane Glycoproteins - metabolism; Membrane Transport Proteins - metabolism; Microviscosity; Middle Aged; Mood disorders; Nerve Tissue Proteins - metabolism; Pharmacology. Drug treatments; Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Serotonin Plasma Membrane Transport Proteins; Serotonin uptake; Simvastatin - adverse effects; Time Factors; Toxicity: nervous system and muscle; Serotonin uptake; Microviscosity; Depression; Impulsivity; Mood disorder; Human; Serotoninergic transmission; Serotonin; Enzyme; Toxicity; Simvastatin; Enzyme inhibitor; Metabolic diseases; Lipids; Hyperlipoproteinemia; Statin derivative; Cholesterol; Hypercholesterolemia; Treatment; Neurotransmitter; Hydroxymethylglutaryl-CoA reductase; Oxidoreductases; Dyslipemia; Antilipemic agent